Text Size

Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents

Tsuji F., Murai M., Oki K., Seki I., Ueda K., Inoue H., Nagelkerken L., Sasano M., Aono H.


  • 2010
  • European Journal of Pharmacology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Other

  • Affiliations

    Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma-shi, Nara, 630-0101, Japan; United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan; Department of Inflammatory and Degenerative Diseases, TNO Quality of Life, Zernikedreef 9, 2333 CK Leiden, Netherlands; Functional Polymer Science Laboratory, Graduate School of Materials Sciences, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma-shi, Nara, 630-0192, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022